Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Atrovent Inhaler CFC-Free

Active Ingredient:
ipratropium bromide monohydrate
Company:  
Boehringer Ingelheim Limited See contact details
ATC code: 
R03BB01
{info_black}
About Medicine
Pressurised metered dose inhalers (pMDI): risk of airway obstruction from aspiration of loose objects (MHRA release July 2018)

Remind patients to check and remove the mouthpiece cover properly before inhaling a dose and to shake the inhaler to remove loose objects that may have become trapped in the inhaler during storage. The mouthpiece cover should be replaced securely after use. We have received reports of patients who have inhaled objects into the back of the throat, resulting in coughing. In some cases, objects were aspirated, causing airway obstruction.

Further information can be found in the MHRA Drug Safety Update
Boehringer Ingelheim Limited
Company image
Address
Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone
+44 (0)1344 424 600
Fax
01344 741444
Medical Information Direct Line
+44 (0)1344 742579
Medical Information e-mail
[email protected]